No abstract available
MeSH terms
-
Adalimumab / therapeutic use
-
Biosimilar Pharmaceuticals* / adverse effects
-
Hidradenitis Suppurativa* / chemically induced
-
Hidradenitis Suppurativa* / complications
-
Hidradenitis Suppurativa* / drug therapy
-
Humans
-
Mevalonate Kinase Deficiency*
-
Psoriasis* / chemically induced
-
Psoriasis* / complications
-
Psoriasis* / drug therapy
-
Ustekinumab / adverse effects
Substances
-
Adalimumab
-
Ustekinumab
-
guselkumab
-
Biosimilar Pharmaceuticals